Skip to main navigation
logo
  • Home
  • Overview
  • News & Events
    • Press Releases
    • Events and Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Financials
    • SEC Filings
    • Annual Reports
    • Quarterly Releases
  • Governance
    • Governance Overview
    • Board of Directors
    • Management
    • Committee Composition
  • IR Resources
    • Email Alerts
    • Contact IR

Press Releases

Press Releases

June 17, 2021
Athira Pharma Chief Operating Officer, Mark Litton, Assumes Day-to-Day Leadership Responsibilities of Company
June 14, 2021
Athira Pharma Appoints Rachel Lenington as Chief Technology Officer, Head of Product Development Strategy
June 9, 2021
Athira Pharma to Present at Upcoming Investor Conferences
June 1, 2021
Athira Pharma Appoints Mark Worthington as General Counsel
May 26, 2021
Athira Pharma to Present at Upcoming Investor Conferences
May 13, 2021
Athira Pharma Reports First Quarter 2021 Financial Results and Provides Business Highlights
April 21, 2021
Athira Pharma to Participate in Panel Discussion at Sachs 4th Annual Neuroscience Innovation Forum
April 8, 2021
Athira Pharma to Host Educational Webinar on Targeting HGF/MET: A Naturally Occurring Neuronal Repair Pathway
March 25, 2021
Athira Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
March 24, 2021
Athira Pharma to Present at Stifel’s 3rd Annual CNS Conference

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Current page 9
  • Page 10
  • Page 11
  • Page 12
  • Next page next ›
  • Last page last »
Displaying 81 - 90 of 116
< SIGN UP FOR EMAIL ALERTS
CONTACT IR

Athira Pharma, Inc.
18706 North Creek Parkway
Suite 104
Bothell, WA 98011

Main line: (866) 725-0930
Local number: (425) 620-8501
info@athira.com

FCOI Policy

Privacy Policy

© Athira Pharma, Inc. All rights reserved.